HRG Antikörper (Middle Region)
Kurzübersicht für HRG Antikörper (Middle Region) (ABIN633918)
Target
Alle HRG Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- HRG antibody was raised against the middle region of HRG
-
Aufreinigung
- Affinity purified
-
Immunogen
- HRG antibody was raised using the middle region of HRG corresponding to a region with amino acids EVLPLPEANFPSFPLPHHKHPLKPDNQPFPQSVSESCPGKFKSGFPQVSM
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
HRG Blocking Peptide, (ABIN938186), is also available for use as a blocking control in assays to test for specificity of this HRG antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of HRG antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- HRG (Histidine-Rich Glycoprotein (HRG))
-
Andere Bezeichnung
- HRG
-
Hintergrund
- This histidine-rich glycoprotein(HRG) contains two cystatin-like domains and is located in plasma and platelets. The physiological function has not been determined but it is known that the protein binds heme, dyes and divalent metal ions. It can inhibit rosette formation and interacts with heparin, thrombospondin and plasminogen. Two of the protein's effects, the inhibition of fibrinolysis and the reduction of inhibition of coagulation, indicate a potential prothrombotic effect. Mutations in this gene lead to thrombophilia due to abnormal histidine-rich glycoprotein levels.
-
Molekulargewicht
- 58 kDa (MW of target protein)
Target
-